VALE3 enters the week of September 15 down nearly 6% over the past five sessions, underperforming most of its peer group even as iron ore pricing remains the dominant headwind and two major institutional holders move in opposite directions.
The institutional picture is the most interesting angle here. Capital Research and Management holds 9.1% of shares and added roughly 32.7 million shares in the most recently reported period — a meaningful build from one of Vale's largest outside holders. BlackRock sits just behind at 8.7% and added an even larger 83.8 million shares. Those are significant additions in absolute terms. The contrast comes further down the register: Arrowstreet Capital trimmed its position by nearly 16 million shares, and Morgan Stanley cut by 16.5 million. Brazilian pension fund PREVI (Caixa de Previdência) and Mitsui held their stakes flat. The picture is not one of broad institutional flight — it is a divergence between long-term holders adding exposure and tactical managers reducing it.
The lending market is essentially uncrowded, and shorts are not a meaningful part of the story here. Availability is effectively unlimited — shares available to borrow run at multiples of the short position — and borrowing costs have fallen sharply, dropping 38% over the past week to around 0.53%, near their lowest level in the trailing data. The ORTEX short score sits at 25, ranking in the 97th percentile for low short pressure. Days-to-cover ranks in the 93rd percentile. This is a stock where bears are not active in the lending market, and the borrow setup offers no particular squeeze dynamic in either direction.
Valuation tells a value-heavy story. The EV/EBITDA multiple sits near 4.8x, which has compressed modestly over the past month and week. The PE is just under 8.7x, also drifting lower. On the factor dashboard, Vale scores in the 100th percentile on EV/EBIT — exceptionally cheap relative to its earnings before interest and taxes. The dividend score ranks in the 92nd percentile, reflecting the August dividend announcement of BRL 0.46 per share. What pulls against those positives is weak earnings trajectory: EPS momentum reads in the 13th-17th percentile over both 30 and 90 days, forward EPS growth ranks in the 3rd percentile, and earnings surprise history ranks in the 16th percentile. The stock is cheap on price-relative metrics but the forward earnings revisions are moving in the wrong direction.
The recent Q2 result captured that tension directly. Vale held its dividend commitment and raised 2026 production guidance, but iron ore price softness put downward pressure on margins. Year-to-date, VALE3 is down roughly 18% on the Bovespa — steeper than most comparable diversified miners. This week's peer performance underscores the relative weakness: BRAP3 fell 3.3% on the week, FCX dropped 9.4%, and RIO gave back 7.6%, suggesting the mining sector more broadly is under pressure from macro and commodity factors rather than anything Vale-specific. Next quarter's print on October 29 will be the next clear test — the question for the market is whether the production guidance upgrade is sufficient to offset continued weakness in realised iron ore prices.
See the live data behind this article on ORTEX.
Open VALE3 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
